Home
Storia in 1 fonti
What RevMed's pancreatic cancer drug meant for one patient
Why did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."
Raccontata da
statnews.com
Timeline cronologica
- ·
Radiopharmaceutical shows promise in post-Pluvicto setting
Abivax's ulcerative colitis data, Fulcrum's scrapped sickle cell drug, and more biotech news from The Readout
- ·
Legend Biotech emerged as a rare market winner
New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout
- ·
What RevMed's pancreatic cancer drug meant for one patient
Why did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."